News | April 24, 2015

Making Waves with Robotic Ultrasound Between New York and Chicago

Icahn School of Medicine, Rush University Medical Center testing long-distance, tele-robotic ultrasound over the Internet

Icahn School of Medicine, Mount Sinai, Rush, tele-robotic ultrasound, telehealth

April 24, 2015 – A new clinical trial is testing the feasibility and efficiency of a doctor in New York City remotely performing long-distance, tele-robotic ultrasound exams over the Internet on patients in Chicago.

The study is a research collaboration between cardiovascular imaging specialists of Icahn School of Medicine at Mount Sinai in New York and Rush University Medical Center in Chicago.

The research team is investigating if remote, long-distance tele-robotic ultrasound exams of the carotid artery in the neck could be just as efficient as traditional, in-person manual ultrasound exams to test for signs of carotid intima-media thickness and carotid atherosclerotic plaque; both conditions are risk factors for cardiovascular events such as heart attack and stroke.

The study, enrolling 100 participants over the age of 60 in Chicago at Rush, is using a small, robotic arm outfitted with ultrasound technology and connected to a personal computer with a standard Internet connection. The robot is controlled over the Internet by a Mount Sinai cardiovascular specialist with the ability to complete a scan of the carotid artery in just 4 minutes. In addition, each patient will also receive a manual, in-person ultrasound exam by Rush to compare detection results.

“Launching long-distance, tele-robotic ultrasound exams between two major hospitals in two large cities is a sign that we may be able to make waves in accelerating access to and cost-effectiveness of this critical heart health imaging diagnostic tool to other cities, small towns, or rural communities in need,” said Partho P. Sengupta, M.D., the study’s principal investigator at Mount Sinai and director of interventional echocardiography and cardiac ultrasound research, and associate professor of medicine (cardiology) at Icahn School of Medicine at Mount Sinai.

“Imaging technology is evolving at a rapid pace. If this tele-health breakthrough proves feasible and successful it may open the door for more accessible screening, prevention, and diagnostic capabilities for patients who may be at high-risk for cardiovascular diseases,” said Rami Doukky, M.D., MSc, the study’s principal investigator at Rush, professor of medicine and radiology at Rush Medical College and the interim chief of cardiology at the John H. Stroger, Jr. Hospital of Cook County in Chicago.

“Our platform brings together remotely controllable robotics, ultrasound and telepresence to allow an experienced operator located anywhere in the world to perform an ultrasound exam at a distance,” said Jeffrey Soble, M.D., associate professor of cardiology at Rush University Medical Center. Soble is one of the creators of the novel tele-robotic healthcare technology being tested called TRUDI (Tele-Robotic Ultrasound for Distance Imaging), a product of the company TeleHealthRobotics which he co-founded with biomedical engineer Sarah Doherty.

This new pioneering clinical trial in the United States, builds upon the recent research breakthrough collaboration of Mount Sinai and TeleHealthRobotics’ technology using remote, long-distance robotic-assisted ultrasound imaging internationally.

While in Germany, Mount Sinai’s Sengupta used TRUDI to perform the first robot-assisted trans-Atlantic ultrasound examination on a person in Boston. “Our successful first-in-man international experiment opened up a new frontier for the use of remote, robotic ultrasound imaging that could potentially be more efficient and cost-effective overall for healthcare delivery,” said Sengupta.

In addition, Mount Sinai and collaborators in Sweden tested the feasibility of similar tele-robotic ultrasound technology within Sweden for heart failure patients at a remote primary care center located a far distance from the nearest Swedish hospital. “Our tele-robotic ultrasound approach reduced the time to care and improved patient satisfaction substantially,” said Jagat Narula, M.D., Ph.D., that study’s senior investigator and Mount Sinai’s director of cardiovascular imaging.

“Our recent research breakthroughs give us a glimpse of what to expect in the near future — a patient-friendly imaging technology at your doorstep,” added Narula.

Valentin Fuster, M.D., Ph.D., director of Mount Sinai Heart at Mount Sinai says: “Tele-robotic imaging may be the key ‘helping hand’ we need to accelerate greater local and global healthcare access.”

For more information: www.mountsinai.org

Related Content

ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along
Medical Imaging Rates Continue to Rise Despite Push to Reduce Their Use
News | Radiology Imaging | September 03, 2019
Despite a broad campaign among physician groups to reduce the amount of medical imaging, use rates of various scans...
Philips Debuts Cardiac Ultrasound and Enterprise Informatics Offerings at ESC 2019
News | Cardiac Imaging | August 30, 2019
Philips will showcase its latest cardiac care innovations at the European Society of Cardiology (ESC) Congress 2019,...
CIRS Launches Ultrasound Quality Assurance Software
Technology | Quality Assurance (QA) | August 30, 2019
August 30, 2019 — The CIRS Ultrasound...
Terason Partners With DiA Imaging Analysis for Point-of-care Cardiac Ultrasound AI
News | Cardiovascular Ultrasound | August 26, 2019
Ultrasound imaging company Terason has partnered with DiA Imaging Analysis, provider of artificial intelligence (AI)-...
Exo Imaging Raises $35 Million for Developmental Ultrasound Platform
News | Ultrasound Imaging | August 23, 2019
Exo Imaging Inc. announced a $35 million Series B financing round for its high-performance ultrasound platform based on...
Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival
News | Prostate Cancer | August 20, 2019
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Contrast Use in First Transthoracic Echocardiogram for Heart Failure Reduces Repeat Testing
News | Cardiovascular Ultrasound | August 07, 2019
Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most common reason for...